4//SEC Filing
Rawcliffe Adrian 4
Accession 0000950170-24-097290
CIK 0001631574other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:00 PM ET
Size
7.3 KB
Accession
0000950170-24-097290
Insider Transaction Report
Form 4
Rawcliffe Adrian
Director
Transactions
- Award
Ordinary Shares
2024-08-12+16,115→ 16,115 total - Award
Share Option (right to buy)
2024-08-12+32,230→ 32,230 totalExercise: $5.37Exp: 2029-08-12→ Ordinary Shares (32,230 underlying)
Footnotes (2)
- [F1]The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025.
- [F2]The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 100% of the shares on the earlier of the Company's 2025 annual general meeting or August 12, 2025.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001555851
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:00 PM ET
- Size
- 7.3 KB